Motavizumab, a neutralizing anti-respiratory syncytial virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model

Virology Journal

Volumn 4, Issue , 2007, Pages

  Mejías, Asunción ^a   Chávez Bueno, Susana ^a   Raynor, Martin B ^a   Connolly, John ^b   Kiener, Peter A ^c   Jafri, Hasan S ^a   Ramilo, Octavio ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Baylor Institute for Immunology   (United States)

^c MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MOTAVIZUMAB; NEUTRALIZING ANTIBODY; RANTES; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DISEASE SEVERITY; DRUG EFFECT; DRUG INHIBITION; FEMALE; IMMUNE RESPONSE; INOCULATION; LUNG LAVAGE; MOUSE; NONHUMAN; PATHOGENESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; DISEASE MODEL; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS CULTURE;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; PLAQUE ASSAY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS REPLICATION;

EID: 38849111202     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-109     Document Type: Article

References (17)

1. Respiratory syncytial virus infection does not increase allergen- induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. RS Peebles Jr. JR Sheller RD Collins AK Jarzecka DB Mitchell RA Parker BS Graham, J Med Virol 2001 63 2 178 188 10.1002/1096-9071(20000201)63:2<178:: AID-JMV1013>3.0.CO;2-O 11170055
2. Bronchiolitis-associated hospitalizations among US children, 1980-1996. DK Shay RC Holman RD Newman LL Liu JW Stout LJ Anderson, Jama 1999 282 15 1440 1446 10.1001/jama.282.15.1440 10535434
3. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. R Alvarez KS Harrod WJ Shieh S Zaki RA Tripp, J Virol 2004 78 24 14003 14011 15564507 10.1128/JVI.78.24.14003-14011.2004
4. Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding Kinetics and Binding Valence on Viral Neutralization. H Wu DS Pfarr Y Tang LL An NK Patel JD Watkins WD Huse PA Kiener JF Young, J Mol Biol 2005
5. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. A Mejias S Chavez-Bueno AM Rios MF Aten B Raynor E Peromingo P Soni KD Olsen PA Kiener AM Gomez HS Jafri O Ramilo, Antimicrob Agents Chemother 2005 49 11 4700 4707 16251314 10.1128/AAC.49.11.4700-4707.2005
6. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model. S Chavez-Bueno A Mejias AM Gomez KD Olsen AM Rios M Fonseca-Aten O Ramilo HS Jafri, Virol J 2005 2 1 46 15916706 10.1186/1743-422X-2-46
7. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. HS Jafri S Chavez-Bueno A Mejias AM Gomez AM Rios SS Nassi M Yusuf P Kapur RD Hardy J Hatfield BB Rogers K Krisher O Ramilo, J Infect Dis 2004 189 10 1856 1865 10.1086/386372 15122522
8. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. A Mejias S Chavez-Bueno AM Rios J Saavedra-Lozano M Fonseca Aten J Hatfield P Kapur AM Gomez HS Jafri O Ramilo, Antimicrob Agents Chemother 2004 48 5 1811 1822 15105140 10.1128/AAC.48.5.1811-1822.2004
9. Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. JL Chunn HW Young SK Banerjee GN Colasurdo MR Blackburn, J Immunol 2001 167 8 4676 4685 11591798
10. Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo. KM Neuzil YW Tang BS Graham, Am J Med Sci 1996 311 5 201 204 10.1097/00000441-199605000-00001 8615393
11. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. T Hussell A Pennycook PJ Openshaw, Eur J Immunol 2001 31 9 2566 2573 10.1002/1521-4141(200109)31:9<2566::AID- IMMU2566>3.0.CO;2-L 11536154
12. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. P Sheeran H Jafri C Carubelli J Saavedra C Johnson K Krisher PJ Sanchez O Ramilo, Pediatr Infect Dis J 1999 18 2 115 122 10.1097/00006454-199902000-00007 10048682
13. Soluble interleukin-2 receptor (sCD25) and interleukin-10 plasma concentrations are associated with severity of primary respiratory syncytial virus (RSV) infection. J Alonso Fernandez I Roine A Vasquez M Caneo, Eur Cytokine Netw 2005 16 1 81 90 15809211
14. The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. MJ Makela A Kanehiro A Dakhama L Borish A Joetham R Tripp L Anderson EW Gelfand, Am J Respir Crit Care Med 2002 165 6 824 831 11897651
15. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. JH Aberle SW Aberle MN Dworzak CW Mandl W Rebhandl G Vollnhofer M Kundi T Popow-Kraupp, Am J Respir Crit Care Med 1999 160 4 1263 1268 10508817
16. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. RP Garofalo J Patti KA Hintz V Hill PL Ogra RC Welliver, J Infect Dis 2001 184 4 393 399 10.1086/322788 11471095
17. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice [In Process Citation]. SM van Schaik N Obot G Enhorning K Hintz K Gross GE Hancock AM Stack RC Welliver, J Med Virol 2000 62 2 257 266 10.1002/1096-9071(200010)62:2<257::AID-JMV19>3.0.CO;2-M 11002257